Clinical trials to test rehabilitation

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Randomized clinical trials (RCTs) are recognized as the gold-standard approach to assessing the efficacy of medical interventions. High-quality (rigorously designed, conducted, and analyzed) RCTs provide reliable evidence on which to base clinical practice. Rehabilitation interventions are widely used in the management of patients with multiple sclerosis (MS); however, relatively few interventions have been evaluated by RCTs. Compared to drug trials, the design and conduct of RCTs to assess rehabilitation presents a number of major problems. This chapter examines sources of error in RCTs in general, discusses specific problems related to rehabilitation trials, and finally summarizes the available evidence regarding the methodological rigor of rehabilitation interventions in MS in three major areas: physiotherapy, cognitive retraining, and multidisciplinary rehabilitation. Clinical aspects of these interventions are discussed in other chapters of this volume. Sources of error in RCTs Randomized clinical trials are susceptible to two main types of error, those due to chance (random departure of results from the truth), and those due to bias (deviation of results from the truth). Many clinicians are familiar with errors due to chance, embodied in the concept of statistical significance or the p value, which estimates whether a difference between, say a treated and a control group, can reasonably be attributed to chance or considered real.

Original languageEnglish
Title of host publicationMultiple Sclerosis: Recovery of Function and Neurorehabilitation
PublisherCambridge University Press
Pages157-164
Number of pages8
ISBN (Print)9780511781698, 9780521888325
DOIs
Publication statusPublished - Jan 1 2010

Fingerprint

Rehabilitation
Randomized Controlled Trials
Clinical Trials
Multiple Sclerosis
Research Design
Drug Design
Gold
Control Groups

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Solari, A. (2010). Clinical trials to test rehabilitation. In Multiple Sclerosis: Recovery of Function and Neurorehabilitation (pp. 157-164). Cambridge University Press. https://doi.org/10.1017/CBO9780511781698.019

Clinical trials to test rehabilitation. / Solari, Alessandra.

Multiple Sclerosis: Recovery of Function and Neurorehabilitation. Cambridge University Press, 2010. p. 157-164.

Research output: Chapter in Book/Report/Conference proceedingChapter

Solari, A 2010, Clinical trials to test rehabilitation. in Multiple Sclerosis: Recovery of Function and Neurorehabilitation. Cambridge University Press, pp. 157-164. https://doi.org/10.1017/CBO9780511781698.019
Solari A. Clinical trials to test rehabilitation. In Multiple Sclerosis: Recovery of Function and Neurorehabilitation. Cambridge University Press. 2010. p. 157-164 https://doi.org/10.1017/CBO9780511781698.019
Solari, Alessandra. / Clinical trials to test rehabilitation. Multiple Sclerosis: Recovery of Function and Neurorehabilitation. Cambridge University Press, 2010. pp. 157-164
@inbook{fcd98f285bb747b695dd191dbae4df0a,
title = "Clinical trials to test rehabilitation",
abstract = "Randomized clinical trials (RCTs) are recognized as the gold-standard approach to assessing the efficacy of medical interventions. High-quality (rigorously designed, conducted, and analyzed) RCTs provide reliable evidence on which to base clinical practice. Rehabilitation interventions are widely used in the management of patients with multiple sclerosis (MS); however, relatively few interventions have been evaluated by RCTs. Compared to drug trials, the design and conduct of RCTs to assess rehabilitation presents a number of major problems. This chapter examines sources of error in RCTs in general, discusses specific problems related to rehabilitation trials, and finally summarizes the available evidence regarding the methodological rigor of rehabilitation interventions in MS in three major areas: physiotherapy, cognitive retraining, and multidisciplinary rehabilitation. Clinical aspects of these interventions are discussed in other chapters of this volume. Sources of error in RCTs Randomized clinical trials are susceptible to two main types of error, those due to chance (random departure of results from the truth), and those due to bias (deviation of results from the truth). Many clinicians are familiar with errors due to chance, embodied in the concept of statistical significance or the p value, which estimates whether a difference between, say a treated and a control group, can reasonably be attributed to chance or considered real.",
author = "Alessandra Solari",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9780511781698.019",
language = "English",
isbn = "9780511781698",
pages = "157--164",
booktitle = "Multiple Sclerosis: Recovery of Function and Neurorehabilitation",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Clinical trials to test rehabilitation

AU - Solari, Alessandra

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Randomized clinical trials (RCTs) are recognized as the gold-standard approach to assessing the efficacy of medical interventions. High-quality (rigorously designed, conducted, and analyzed) RCTs provide reliable evidence on which to base clinical practice. Rehabilitation interventions are widely used in the management of patients with multiple sclerosis (MS); however, relatively few interventions have been evaluated by RCTs. Compared to drug trials, the design and conduct of RCTs to assess rehabilitation presents a number of major problems. This chapter examines sources of error in RCTs in general, discusses specific problems related to rehabilitation trials, and finally summarizes the available evidence regarding the methodological rigor of rehabilitation interventions in MS in three major areas: physiotherapy, cognitive retraining, and multidisciplinary rehabilitation. Clinical aspects of these interventions are discussed in other chapters of this volume. Sources of error in RCTs Randomized clinical trials are susceptible to two main types of error, those due to chance (random departure of results from the truth), and those due to bias (deviation of results from the truth). Many clinicians are familiar with errors due to chance, embodied in the concept of statistical significance or the p value, which estimates whether a difference between, say a treated and a control group, can reasonably be attributed to chance or considered real.

AB - Randomized clinical trials (RCTs) are recognized as the gold-standard approach to assessing the efficacy of medical interventions. High-quality (rigorously designed, conducted, and analyzed) RCTs provide reliable evidence on which to base clinical practice. Rehabilitation interventions are widely used in the management of patients with multiple sclerosis (MS); however, relatively few interventions have been evaluated by RCTs. Compared to drug trials, the design and conduct of RCTs to assess rehabilitation presents a number of major problems. This chapter examines sources of error in RCTs in general, discusses specific problems related to rehabilitation trials, and finally summarizes the available evidence regarding the methodological rigor of rehabilitation interventions in MS in three major areas: physiotherapy, cognitive retraining, and multidisciplinary rehabilitation. Clinical aspects of these interventions are discussed in other chapters of this volume. Sources of error in RCTs Randomized clinical trials are susceptible to two main types of error, those due to chance (random departure of results from the truth), and those due to bias (deviation of results from the truth). Many clinicians are familiar with errors due to chance, embodied in the concept of statistical significance or the p value, which estimates whether a difference between, say a treated and a control group, can reasonably be attributed to chance or considered real.

UR - http://www.scopus.com/inward/record.url?scp=84927036101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927036101&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511781698.019

DO - 10.1017/CBO9780511781698.019

M3 - Chapter

AN - SCOPUS:84927036101

SN - 9780511781698

SN - 9780521888325

SP - 157

EP - 164

BT - Multiple Sclerosis: Recovery of Function and Neurorehabilitation

PB - Cambridge University Press

ER -